Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · IEX Real-Time Price · USD
0.730
-0.001 (-0.14%)
Jul 22, 2024, 10:13 AM EDT - Market open
Bolt Biotherapeutics Employees
Bolt Biotherapeutics had 100 employees as of December 31, 2023. The number of employees increased by 6 or 6.38% compared to the previous year.
Employees
100
Change (1Y)
6
Growth (1Y)
6.38%
Revenue / Employee
$113,240
Profits / Employee
-$630,280
Market Cap
27.83M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 100 | 6 | 6.38% |
Dec 31, 2022 | 94 | 3 | 3.30% |
Dec 31, 2021 | 91 | 26 | 40.00% |
Dec 31, 2020 | 65 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Renalytix | 102 |
Enlivex Therapeutics | 71 |
Surrozen | 42 |
Palatin Technologies | 34 |
Acasti Pharma | 32 |
Brainstorm Cell Therapeutics | 29 |
bioAffinity Technologies | 14 |
Akari Therapeutics, | 12 |
BOLT News
- 34 minutes ago - BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Accesswire
- 20 hours ago - BOLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bolt Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - GlobeNewsWire
- 1 day ago - BOLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - Accesswire
- 2 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BOLT - GlobeNewsWire
- 2 days ago - ROSEN, LEADING INVESTOR COUNSEL, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT - GlobeNewsWire
- 2 days ago - Faruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on September 3, 2024 in Bolt Lawsuit - PRNewsWire
- 3 days ago - BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Accesswire
- 3 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BOLT - PRNewsWire